Skip to main content
. Author manuscript; available in PMC: 2009 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2008 Jul 4;232(2):169–179. doi: 10.1016/j.taap.2008.06.017

Fig. 6.

Fig. 6

Binding of a fluorescent pan-caspase inhibitor to pAA-exposed MCF10A cultures. Cultures were treated with DMSO or pAA (25 or 100 μM) for 24, 48 or 72 h prior to being exposed to FAM-VAD-FMK, and processed and analyzed as described in Materials and Methods. FACS was used to monitor cell-bound fluorescent caspase inhibitor. Data represent 104 scored events.